Dr. Sally A. Burtle, MD

Dr. Burtle practices at Greenbrae Dermatology, a Medical Corporation in Greenbrae, California.

Dr. Burtle's NPI, 1821093972, was assigned on June 16, 2005. Dr. Burtle graduated from Drexel University College Of Medicine in 2000. Dr. Burtle's California license number on file is A94836.

Dr. Burtle's primary practice is Greenbrae Dermatology, a Medical Corporation, at 501 Sir Francis Drake Blvd, Greenbrae, CA 94904 in Marin County. The practice phone is (415) 925-0550.

Dr. Burtle's primary practice is Greenbrae Dermatology, a Medical Corporation in Greenbrae, California. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Burtle to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burtle practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Burtle's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Burtle is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Burtle's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 518 Medicare services from Dr. Burtle across 9 procedure codes in 2024, for 169 Medicare patients. Medicare paid $28,466 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Burtle in 2024. The largest group is 65 to 74, with 74 patients. 69% of them have high cholesterol, and 50% have high blood pressure. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Burtle's median patient age at 53, with 57% women.

In 2024, Dr. Burtle wrote 111 Medicare Part D claims for 69 patients. 96% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $584 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Burtle for performance year 2024, reported as part of a group. Dr. Burtle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 588 procedures of removal of skin lesions by Dr. Burtle, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 40 general payments to Dr. Burtle from 12 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $413.

Dmand AI lists 2 awards for Dr. Burtle, most recently CMS Stage 1 2012 in 2011.

Dr. Burtle graduated from Drexel University College Of Medicine in 2000. Dr. Burtle is a member of AAD.

Dr. Burtle is in network with 4 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.